Running summarizing tools on a new article
Check the paper below, then start its synthesis.
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures
Andrew J. Fiore-Gartland (Fred Hutch Cancer Center), Koshlan Mayer-Blackwell (Fred Hutch Cancer Center), James E. Stray (Adaptive Biotechnologies (United States)), Moni Blazej Neradilek (Fred Hutch Cancer Center), April Lo (Adaptive Biotechnologies (United States)), Alex Hannah (Adaptive Biotechnologies (United States)), Tracy Qi Dong (Fred Hutch Cancer Center), Leonid Serebryannyy (National Institutes of Health, National Institute of Allergy and Infectious Diseases), Robin Carroll (National Institutes of Health, National Institute of Allergy and Infectious Diseases), Bob C. Lin (National Institutes of Health, National Institute of Allergy and Infectious Diseases), R. A. Koup (National Institutes of Health, National Institute of Allergy and Infectious Diseases), Nina Marie G. Garcia (Fred Hutch Cancer Center), Jasmine Riviere Marcelin (University of Nebraska Medical Center), Audrey E. Pettifor (University of North Carolina at Chapel Hill), Holly Janes (Fred Hutch Cancer Center), Elizabeth R. Brown (Fred Hutch Cancer Center), Catherine Yen (National Institutes of Health, National Institute of Allergy and Infectious Diseases), Jessica G. Andriesen (Fred Hutch Cancer Center), Lawrence Corey (Fred Hutch Cancer Center), Kathryn E. Stephenson (Beth Israel Deaconess Medical Center, Harvard University), James G Kublin (Fred Hutch Cancer Center)
Abstract: Background: The cellular and neutralizing antibody responses to SARS-CoV-2 infection are complex, particularly with multiple and heterogeneous exposures. We sought to understand the changes to the antibody and T-cell repertoire elicited by mildly symptomatic or asymptomatic infections in young adults, and how immune responses to prior vaccination may interact with new viral exposures in this population. Additionally, profiling both aspects of humoral and cellular immunity from a single vial of blood is experimentally challenging. Methods: = 209 participants). We sequenced TCR repertoires and measured anti-SARS-CoV-2 antibody responses from pre-exposure, post-vaccination, and post-breakthrough blood samples. Results: Clot material provided suitable genomic DNA for TCR profiling, with vaccination and infection leading to expansions in T-cell responses. Consistent with prior studies, we found that hybrid immunological exposures (vaccination after infection) lead to the greatest antibody potency and spike TCR breadth. When the order of exposure was reversed, we observed evidence of attenuated disease severity (reduced shedding duration and lower peak nasal viral load) in post-vaccination versus primary infections. Discussion: The protocols described here for recovery of TCR repertoires from remnant coagulated material will facilitate more common estimation of cellular and neutralizing antibody immune responses as potential correlates of protection in large clinical trial cohorts where peripheral blood mononuclear cell (PBMC) acquisition or analysis is otherwise infeasible.